Johns Hopkins ABX Guide
Meropenem/vaborbactam
INDICATIONS
FDA
FDA
- Treatment of complicated urinary tract infections (cUTIs) including pyelonephritis caused by designated susceptible bacteria in adult patients (≥18 years of age)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 16, 2018
Citation
Avdic, Edina. "Meropenem/vaborbactam." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540687/all/Meropenem_vaborbactam.
Avdic E. Meropenem/vaborbactam. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540687/all/Meropenem_vaborbactam. Accessed October 14, 2024.
Avdic, E. (2018). Meropenem/vaborbactam. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540687/all/Meropenem_vaborbactam
Avdic E. Meropenem/vaborbactam [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2024 October 14]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540687/all/Meropenem_vaborbactam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Meropenem/vaborbactam
ID - 540687
A1 - Avdic,Edina,Pharm.D.
Y1 - 2018/01/16/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540687/all/Meropenem_vaborbactam
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
